Webb David Ritchie 4
4 · Sorrento Therapeutics, Inc. · Filed Oct 19, 2012
Insider Transaction Report
Form 4
Webb David Ritchie
Director
Transactions
- Award
Non-qualified stock option
2012-10-17+450,000→ 450,000 totalExercise: $0.16Exp: 2022-10-17→ Common Stock (450,000 underlying) - Disposition to Issuer
Non-qualified stock option
2012-10-17−37,500→ 0 totalExercise: $0.14Exp: 2021-09-28→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]1/48 of the original number of shares subject to this option shall vest and become exercisable following each one-month period of service starting on September 6, 2012, subject to the reporting person's continued service on the issuer's board of directors on each such date.
- [F2]These options were surrendered to the issuer by the reporting person.
- [F3]1/4 of the original number of shares subject to this option vested on September 28, 2012 and 1/4 of the original number of shares subject to this option shall vest on each anniversary thereafter, subject to the reporting person's continued service to the issuer through each such vesting date.